W
William Collins
Researcher at Stanford University
Publications - 5
Citations - 215
William Collins is an academic researcher from Stanford University. The author has contributed to research in topics: Public health & Efficacy. The author has an hindex of 5, co-authored 5 publications receiving 106 citations. Previous affiliations of William Collins include University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Vaccines and Allergic reactions: the past, the current COVID-19 pandemic, and future perspectives.
Vanitha Sampath,Grace Rabinowitz,Mihir Shah,Surabhi Jain,Zuzana Diamant,Milos Jesenak,Ronald L. Rabin,Stefan Vieths,Ioana Agache,Mübeccel Akdis,Domingo Barber,Heimo Breiteneder,Sharon Chinthrajah,Tomas Chivato,William Collins,Thomas Eiwegger,Katharine Fast,Wytske Fokkens,Robyn E O'Hehir,Markus Ollert,Liam O'Mahony,Oscar Palomares,Oliver Pfaar,Carmen Riggioni,Mohamed H. Shamji,Milena Sokolowska,María José Torres,Claudia Traidl-Hoffmann,Menno C. van Zelm,De Yun Wang,Luo Zhang,Cezmi A. Akdis,Kari C. Nadeau +32 more
TL;DR: In this article, the authors provide an overview of different types of allergic adverse reactions that can potentially occur after vaccination and individual vaccine components capable of causing the allergic adverse reaction and their implications for individual diagnosis and management and vaccine manufacturing overall.
Journal ArticleDOI
Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.
Lauren E. Eggert,Ziyuan He,William Collins,Alexandra S. Lee,Gopal Krishna R. Dhondalay,Shirley Y. Jiang,Jessica Fitzpatrick,Theo T Snow,Benjamin A. Pinsky,Maja Artandi,Linda Barman,Rajan Puri,Richard Wittman,Neera Ahuja,Andra L. Blomkalns,Ruth O'Hara,Shu Cao,Manisha Desai,Sayantani B. Sindher,Kari C. Nadeau,R. Sharon Chinthrajah +20 more
TL;DR: Asthma is not a risk factor for more severe COVID-19 disease and allergic asthmatics were half as likely to be hospitalized with CO VID-19 compared to non-allergic astHmatics, and lower levels of eosinophil counts (allergic biomarkers) were associated with a more severeCOVID- 19 disease trajectory.
Journal ArticleDOI
The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995–2005
TL;DR: Criteria for defining appropriate, standardized genotyping methods for use in different settings are needed to enable more accurate estimates of antimalarial drug efficacy and better comparison between trials.
Journal ArticleDOI
NOTCH1 regulates matrix gla protein and calcification gene networks in human valve endothelium.
Mark P. White,Christina V. Theodoris,Lei Liu,William Collins,Kathleen W. Blue,Joon H. Lee,Xianzhong Meng,Robert C. Robbins,Kathryn N. Ivey,Deepak Srivastava +9 more
TL;DR: It is suggested that shear stress activates NOTCH1 in primary human aortic valve endothelial cells leading to downregulation of osteoblast-like gene networks that play a role in tissue calcification.
Journal ArticleDOI
COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic
Anna L. Parks,Andrew D. Auerbach,Jeffrey L. Schnipper,James E. Anstey,David G. Sterken,Todd E.H. Hecht,Margaret C. Fang,Valerie M. Vaughn,Andrew Dunn,Anne S. Linker,Daniel P. Hunt,Justin J Choi,Daniel J. Brotman,Michael B. Streiff,Melissa L. P. Mattison,Matthew A. Pappas,S Ryan Greysen,David F. Hemsey,Kwame Dapaah-Afriyie,Neera Ahuja,William Collins,Shoshana J. Herzig,Sanjay Bhandari,Eric R. Schumacher,Vijay Duggirala,Kevin J. O'Leary,Geraldine E. Ménard,Michael Y. Lin +27 more
TL;DR: This work collected and analyzed protocols from 21 US academic medical centers developed between January and May 2020 and found greatest consensus on recommendations for heparin-based pharmacologic venous thromboembolism (VTE) prophylaxis in COVID-19 patients without contraindications.